Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: The D-SSIGN score

被引:68
|
作者
Houston Thompson, R.
Leibovich, Bradley C.
Lohse, Christine M.
Cheville, John C.
Zincke, Horst
Blute, Michael L.
Frank, Igor
机构
[1] Mayo Clin, Mayo Med Sch, Dept Urol, Rochester, MN 55905 USA
[2] Mayo Clin, Mayo Med Sch, Dept Hlth Sci Res, Rochester, MN 55905 USA
[3] Mayo Clin, Mayo Med Sch, Dept Lab Med & Pathol, Rochester, MN 55905 USA
来源
JOURNAL OF UROLOGY | 2007年 / 177卷 / 02期
关键词
kidney; carcinoma; renal cell; mortality; nephrectomy; forecasting;
D O I
10.1016/j.juro.2006.09.057
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To date all prediction models for patients with renal cell carcinoma have estimated outcome in static fashion starting from the date of surgery only. We created a dynamic outcome prediction model for continual surveillance that accounts for the disease-free interval following surgery. Materials and Methods: We identified 1,560 patients treated with radical nephrectomy for pM0 clear cell renal cell carcinoma between 1970 and 1999. The previously published stage, size, grade and necrosis score was used to stratify patients according to the risk of death from renal cell carcinoma. Cancer specific survival rates were calculated using the Kaplan-Meier method at surgery and at various disease-free intervals following surgery. Results: At last followup 461 of the 1,560 patients had died of renal cell carcinoma at a median of 3.1 years following surgery. Median followup in patients still alive was 11.2 years. Patient outcome improved as the disease-free interval following surgery increased. For example, patients with a stage, size, grade and necrosis score of 5 had an estimated 5-year cancer specific survival rate of 69.6% at surgery. However, those who survived without disease for 1, 2 and 3 years following surgery had adjusted estimated 5-year cancer specific survival rates of 81.9%, 91.9% and 93.2%, respectively. Patients with a stage, size, grade and necrosis score of 7 had a 5-year cancer specific survival rate of 44.9% at surgery, which increased to 63.3%, 71.0% and 72.8% after 1 to 3 years of disease-free followup, respectively. Conclusions: Within each stage, size, grade and necrosis score cancer specific survival rates increase as the disease-free interval following surgery increases. We present a dynamic outcome prediction model that allows clinicians to continually adjust surveillance as the disease-free interval increases.
引用
收藏
页码:477 / 480
页数:4
相关论文
共 50 条
  • [1] Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy
    Frank, I
    Leibovich, BC
    Lohse, CM
    Cheville, JC
    Zincke, H
    Blute, ML
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 28 - 28
  • [2] An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: The SSIGN score
    Frank, I
    Blute, ML
    Cheville, JC
    Lohse, CM
    Weaver, AL
    Zincke, H
    [J]. JOURNAL OF UROLOGY, 2002, 168 (06): : 2395 - 2400
  • [3] Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients
    Parker, William P.
    Cheville, John C.
    Frank, Igor
    Zaid, Harras B.
    Lohse, Christine M.
    Boorjian, Stephen A.
    Leibovich, Bradley C.
    Thompson, R. Houston
    [J]. EUROPEAN UROLOGY, 2017, 71 (04) : 665 - 673
  • [4] Association of paraneoplastic syndromes with outcome following radical nephrectomy for clear cell renal cell carcinoma
    Magera, JS
    Leibovich, BC
    Cheville, JC
    Lohse, CM
    Zincke, H
    Blute, ML
    [J]. JOURNAL OF UROLOGY, 2004, 171 (04): : 471 - 472
  • [5] Loss of chromosome 9p in clear cell renal cell carcinoma with different SSIGN score
    Brunelli, M.
    Eccher, A.
    Gobbo, S.
    Mina, M. M.
    Cossu-Rocca, P.
    Ficarra, V.
    Menestrina, F.
    Martignoni, G.
    [J]. MODERN PATHOLOGY, 2007, 20 : 138A - 138A
  • [6] Loss of chromosome 9p in clear cell renal cell carcinoma with different SSIGN score
    Brunelli, A.
    Eccher, A.
    Gobbo, S.
    Mina, M. M.
    Cossu-Rocca, P.
    Ficarra, V.
    Menestrina, F.
    Martignoni, G.
    [J]. LABORATORY INVESTIGATION, 2007, 87 : 138A - 138A
  • [7] Prognostic score for patients with localized renal cell carcinoma treated by nephrectomy
    Nativ, O
    Sabo, E
    Madeb, R
    Halachmi, S
    Madjar, S
    Moskovitz, B
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2001, 3 (01): : 24 - 27
  • [8] Prognostic role of SSIGN score in renal cell carcinoma
    Palazzo, S.
    Lucarellii, G.
    Palella, G.
    Impedovo, S.
    Ditonno, P.
    Battaglia, M.
    Selvaggi, F. P.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 282 - 282
  • [9] Proportion of patients eligible for adjuvant immunotherapy in nonmetastatic clear-cell renal cell carcinoma treated with radical or partial nephrectomy
    Tanaka, Ryuma
    Hatakeyama, Shingo
    Miura, Hikari
    Hamaya, Tomoko
    Yoneyama, Takahiro
    Ohyama, Chikara
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (10) : 1235 - 1237
  • [10] Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma - A stratification tool for prospective clinical trials
    Leibovich, BC
    Blute, ML
    Cheville, JC
    Lohse, CM
    Frank, I
    Kwon, ED
    Weaver, AL
    Parker, AS
    Zincke, H
    [J]. CANCER, 2003, 97 (07) : 1663 - 1671